Difference between revisions of "Giulino-Roth L, et al. Mol. cancer therapeutics (2017) cited as Ref 364 in DOI: 10.1038/s41392-020-0110-5 (Q9627)"

@@ Property / First Author string @@
+Giulino-Roth L
@@ Property / First Author string: Giulino-Roth L / rank @@
+Normal rank
@@ Property / DOI Identifier @@
+.1158/1535-7163.MCT-16-0848
@@ Property / DOI Identifier: 10.1158/1535-7163.MCT-16-0848 / rank @@
+Normal rank
@@ Property / Publication Date @@
+Timestamp +2017-01-01T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 year
Before 0
After 0
-Timestamp
++2017-01-01T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+year
 Before
 After
@@ Property / Publication Date: 2017 / rank @@
+Normal rank
@@ Property / Published In Name String @@
+Mol. cancer therapeutics
@@ Property / Published In Name String: Mol. cancer therapeutics / rank @@
+Normal rank
@@ Property / Volume @@
@@ Property / Volume: 16 / rank @@
+Normal rank
@@ Property / title @@
+Inhibition of Hsp90 suppresses PI3K/AKT/mTOR signaling and has antitumor activity in Burkitt lymphoma (English)
+Normal rank
@@ Property / Page(s) @@
+-1790
@@ Property / Page(s): 1779-1790 / rank @@
+Normal rank
@@ links / sliswiki / name / links / sliswiki / name @@
+Giulino-Roth L, et al. Mol. cancer therapeutics (2017) cited as Ref 364 in DOI: 10.1038/s41392-020-0110-5

Latest revision as of 15:39, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

Language	Label	Description	Also known as
English	Giulino-Roth L, et al. Mol. cancer therapeutics (2017) cited as Ref 364 in DOI: 10.1038/s41392-020-0110-5	Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8